logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
15/05/2025
Needham: Maintains a buy rating on Inozyme Pharma (INZY.US), adjusted from a buy rating to a buy rating, with a target price adjusted from $15.00 to $12.00.
Latest
4 m ago
UnitedHealth Group is under investigation by the US Department of Justice for alleged criminal fraud.
4 m ago
United Health Group is under investigation by the US Department of Justice for suspected criminal fraud.
5 m ago
Industry supervision continues to strengthen, Shanghai and Zhejiang initiate self-inspection of private equity funds.
7 m ago
US crude oil futures fell more than $1 to $62.13 per barrel.
8 m ago
The UK is asking antitrust regulators to focus on economic growth.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.